Generic, cancer-killing Israeli drug approved for marketing by FDA
The drug, and the company that makes it, is located in Jerusalem and was developed by Prof. Yechezkel Barenholz.
Prof. Yechezkel Barenholz is seen holding Ayana’s Doxorubicin-HCI Liposomal Injection, a generic cancer-killing drug.(photo credit: YOAV DUDKEVITCH)ByMAAYAN JAFFE-HOFFMAN
